This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2030 Remove Cannabinoids Remove Sleep Remove THC
article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

JUNE 7, 2021

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. As previously disclosed, IGC submitted IGC-AD1 to the U.S. www.igcinc.us

Clinical Trials 105
Clinical Trials Patients THC Safety 105
article thumbnail

Federation of Agricultural Commodity Association of Nigeria (FACAN), is lobbying Federal Government to review export policy to accommodate cannabis

Cannabis Law Report

NOVEMBER 16, 2019

In the same vein, renowned entertainer, Don Jazzy, also urged the Gederal Government to take advantage of cannabis for export, saying that global cannabis industry was projected to hit about $200 billion in earnings by 2030. According to him, THC is the lipid in cannabis, which gives the high sensation noticeable in the display of smokers.

Agriculture 45
Agriculture Policy Oil Hemp 45
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024